Cardiovascular outcomes and prescribing in dementia (CVOPD)
Although many people with dementia have heart conditions, there are currently no guidelines for prescribing and monitoring of cholinesterase inhibitors in heart disease. The study will investigate safety of cholinesterase inhibitors in patients with dementia, including those with heart conditions.